Skip to content

Homoeopathic treatment of scabies in children

Comparing clinical cure achieved with individualized homoeopathic medicines vs standard care in treatment of scabies in children: A comparative cohort study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051248
Enrollment
100
Registered
2023-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B86- Scabies

Interventions

Intervention1: Individualized homeopathic medicines plus concomitant care: Intervention is planned as administering the indicated homeopathic medicines in centesimal potencies (CH). Each dose will con
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

Sponsors

D N De Homoeopathic Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Confirmed cases of scabies (ICD-10 code B86): Clinical findings typical of scabies (burrows, erythematous papules, itching at night time, mite tunnels, macular or papular rashes with severe itching as main symptoms in web spaces, groin, other body parts, mite burrow in the webbed spaces of finger, flexor surface of wrist, elbows, axillae, belt line, feet, scrotum (male child), areolae (female child), nodular scabies, etc.) 2. Dermatoscopic detection of mite, eggs, and soils 3. Children between 5 and 18 years of age 4. Participants and/or guardians providing with written informed assent and/or consent voluntarily 5. Illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires

Exclusion criteria

Exclusion criteria: 1. Severely immune compromised and with fatal systemic symptoms. 2. Participant with history of hypersensitivity reaction on any topical application. 3. Participant with other chronic disorders like juvenile diabetes, nephrotic syndrome, tuberculosis etc. 4. Scabies associated with any other disease. 5. Secondary bacterial infection of scabies. 6. Norwegian scabies. 7. Skin conditions that could make it difficult to evaluate the extent of an infestation or would present a problem in the evaluation of response to therapy (e.g., atopic dermatitis, eczema, contact dermatitis, lichen planus, papular urticaria, seborrheic dermatitis) 8. Substance abuse and/or dependence. 9. Already undergoing homoeopathic treatment for scabies or any other chronic diseases within last 2 months. 10. Simultaneous participation in any other clinical trials

Design outcomes

Primary

MeasureTime frame
The number of children revealing clinical cure. â??Clinical cureâ?? is defined as the improvement of lesions of scabies with no new lesions occurring since initiation of the treatment.Timepoint: 2 months

Secondary

MeasureTime frame
CDLQI questionnaireTimepoint: Baseline, every month, up to 2 months;DLQI questionnaireTimepoint: Baseline, every month, up to 2 months;Skindex-29 questionnaireTimepoint: Baseline, every month, up to 2 months

Countries

India

Contacts

Public ContactMd Sakhawat Hossain

D N De Homoeopathic Medical College & Hospital

imdrmsh@gmail.com9433852961

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026